GeoVax shareholders approve all proposals at annual meeting; quorum reduced to 33 1/3%

GeoVax Labs, Inc.

All seven director nominees elected with between 440,096 and 517,969 votes for.
Proposal to approve issuance of up to 1,408,998 shares upon warrant exercise passed (480,421 for vs 69,206 against).
Bylaw amendment reducing stockholder quorum from majority to 33 1/3% approved (489,102 for, 61,758 against).
Ratification of Wipfli LLP as independent auditor for FY 2024 approved (1,090,966 for, 53,665 against).
Proxies represented 1,177,811 of 2,308,309 outstanding shares as of March 25, 2024 record date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.